For Immediate Release
Chicago, IL – September 22, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. (
MSFT Quick Quote MSFT - Free Report) , Danaher Corp. ( DHR Quick Quote DHR - Free Report) , Raytheon Technologies Corp. ( RTX Quick Quote RTX - Free Report) , Stryker Corporation ( SYK Quick Quote SYK - Free Report) and Vale S.A. ( VALE Quick Quote VALE - Free Report) . Here are highlights from Wednesday’s Analyst Blog: Top Stock Reports for Microsoft, Danaher and Raytheon
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp., Danaher Corp. and Raytheon Technologies Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
see all of today’s research reports here >>> Microsoft shares have declined -18.3% over the past year against the Zacks Computer - Software industry’s decline of -25.6%, reflecting the dominance of its Azure cloud platform amid accelerated global digital transformation. That said, the company’s increasing spend on Azure enhancements amid stiff competition in the cloud space from Amazon is likely to dent margins.
Teams’ user growth is gaining from continuation of remote work and mainstream adoption of hybrid/flexible work model. Recovery in advertising and job market boosted LinkedIn and Search revenues. Solid uptake of new Xbox consoles is aiding the gaming segment performance.
The company is witnessing growth in user base of its different applications including Microsoft 365 suite, Dynamics and Power Platform. Microsoft expects Surface revenues to grow in the mid-teens range, driven by strong demand for premium devices.
) read the full research report on Microsoft here >>> Danaher shares have declined -14.2% over the past year against the Zacks Diversified Operations industry’s decline of -26.5%. Danaher’s diversified business structure allows it to mitigate risks in one end market with strength across the others. Danaher also stands to benefit from Danaher Business System (DBS), healthy rewards to its shareholders, buyout benefits and product innovation in the quarters ahead.
Also, solid traction of Danaher’s Life Sciences business, fueled by healthy demand for bioprocessing products, may drive its revenues in the quarters ahead. The company’s measures to reward its shareholders are encouraging.
) read the full research report on Danaher here >>> Raytheon Technologies shares have outperformed the Zacks Aerospace - Defense Equipment industry over the past year (+2.3% vs. -3.6%). The company continues to receive ample orders for its combat-proven defense products from the Pentagon. A steady recovery in commercial air traffic has been boosting commercial OEM as well as commercial aftermarket sales for Raytheon in the recent times.
It achieved $80 million of incremental merger synergies in the second quarter and aims at achieving $335 million of incremental cost synergies during 2022. The stock holds a solid solvency position.
Yet, economic sanctions imposed by governments in response to Russia’s invasion in Ukraine might hurt Raytheon. A comparative analysis of its trailing 12-month Price/Book ratio reflects a relatively gloomy picture. Purchase order declines, with original equipment manufacturer customers delaying orders, pose a risk to the stock.
) read the full research report on Raytheon Technologies here >>>
Other noteworthy reports we are featuring today include Stryker Corporation and Vale S.A.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared
+40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation. See Stocks Free >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.